Atomistry » Sodium » PDB 9fe5-9icl » 9fjx
Atomistry »
  Sodium »
    PDB 9fe5-9icl »
      9fjx »

Sodium in PDB 9fjx: Crystal Structure of Human Crbn-DDB1 in Complex with Lenalidomide

Protein crystallography data

The structure of Crystal Structure of Human Crbn-DDB1 in Complex with Lenalidomide, PDB code: 9fjx was solved by Y.-V.Le Bihan, R.L.M.Van Montfort, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 20.15 / 2.00
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 71.673, 129.068, 198.446, 90, 90, 90
R / Rfree (%) 19.6 / 23.2

Other elements in 9fjx:

The structure of Crystal Structure of Human Crbn-DDB1 in Complex with Lenalidomide also contains other interesting chemical elements:

Zinc (Zn) 1 atom

Sodium Binding Sites:

The binding sites of Sodium atom in the Crystal Structure of Human Crbn-DDB1 in Complex with Lenalidomide (pdb code 9fjx). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Crystal Structure of Human Crbn-DDB1 in Complex with Lenalidomide, PDB code: 9fjx:

Sodium binding site 1 out of 1 in 9fjx

Go back to Sodium Binding Sites List in 9fjx
Sodium binding site 1 out of 1 in the Crystal Structure of Human Crbn-DDB1 in Complex with Lenalidomide


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Crystal Structure of Human Crbn-DDB1 in Complex with Lenalidomide within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Na505

b:72.8
occ:1.00
O B:HOH887 3.3 58.4 1.0
OD1 B:ASP279 3.8 54.5 1.0
CG2 B:ILE278 4.0 41.1 1.0
OD2 B:ASP279 4.2 56.7 1.0
CD1 B:ILE278 4.2 43.1 1.0
CG B:ASP279 4.3 53.1 1.0
CB B:ILE278 4.4 41.0 1.0
O B:HOH872 4.4 58.0 1.0
ND2 B:ASN276 4.4 57.1 1.0
CG B:ASN276 4.9 56.0 1.0
CG1 B:ILE278 5.0 41.9 1.0

Reference:

Y.Chrisochoidou, A.Scarpino Dr, S.Morales, S.Martin, S.A.Bird, Y.Li Dr, B.A.Walker, J.Caldwell, Y.V.Le Bihan Dr, C.Pawlyn Dr. Evaluating the Impact of Crbn Mutations on Response to Immunomodulatory Drugs and Novel Crbn-Binding Agents in Myeloma. Blood 2025.
ISSN: ESSN 1528-0020
PubMed: 39841463
DOI: 10.1182/BLOOD.2024025861
Page generated: Sun Feb 9 08:43:00 2025

Last articles

Fe in 2YXO
Fe in 2YRS
Fe in 2YXC
Fe in 2YNM
Fe in 2YVJ
Fe in 2YP1
Fe in 2YU2
Fe in 2YU1
Fe in 2YQB
Fe in 2YOO
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy